Britain’s top menopause specialists have released a warning for women who bleed while on high doses of hormone replacement therapy.
It comes after a surge in cases of patients on the drugs being sent for cancer tests.
Guidance from the British Menopause Society (BMS) reassures women that bleeding is a common side effect within three to six months of starting or changing HRT.